Merck Looks Ahead Despite Vioxx Suits
105898
Merck &amp; Co. officials said Tuesday they intend to defend aggressively their handling of the painkiller Vioxx against claims by patients who say they were harmed by the now-withdrawn drug.
26459
Drugmaker Sanofi-Aventis , the target of a lawsuit seeking class-action status filed on behalf of shareholders, on Friday vowed to fight allegations it hid the side-effects of its anti-obesity drug Acomplia.
217345
Merck&#39;s (MRK:NYSE - news - research) withdrawn painkiller, Vioxx, could soon leave pharmacy benefit manager (PBM) Medco (MHS:NYSE - news - research) with its own headaches.
462652
Merck & Co. Inc., reeling from the  recent withdrawal of its Vioxx arthritis drug, on Wednesday  said 2005 earnings will decline to levels below Wall Street  expectations, the third straight year of lower results.
541938
Merck & Co. faces a dual threat from health insurers and patients' lawyers, after a U.S. study suggested its Vioxx arthritis drug carries a greater risk than rival medicines.
438884
Drugmaker Sanofi-Aventis , the  target of a lawsuit seeking class-action status filed on behalf  of shareholders, on Friday vowed to fight allegations it hid  the side-effects of its anti-obesity drug Acomplia.
740825
ATLANTIC CITY, New Jersey  - Merck & Co.  failed to provide adequate warnings about health risks tied to its withdrawn arthritis drug Vioxx in one case, but gave adequate warning in another, a New Jersey jury found on Friday in a split decision in two suits tried simultaneously.
115610
Faced with credibility questions about the Vioxx recall, Merck executives yesterday insisted the first clear signs linking the painkiller to heart problems emerged only last month.
299155
The pharmaceutical firm Merck faces a new class-action lawsuit in Canada, filed on behalf of two people who suffered heart attacks after taking the company's pain medication Vioxx, which was taken off the market worldwide because of such risks, plaintiffs' lawyers said.
22491
Raymond Gilmartin, chief executive of Merck, will testify before a Senate committee this week on the withdrawal of Vioxx, in spite of efforts by the drug company to send others in his place.
667
The Food and Drug Administration insists that until pharmaceutical giant Merck presented new information this week, there was not enough evidence to pull the arthritis drug Vioxx off the market.
22206
Internal e-mails and other documents from Merck &amp; Co. show the company fought for years to keep safety concerns from undermining the drug&#39;s commercial prospects, the Wall Street Journal reported on Monday.
414077
NEW YORK -- Merck &amp; Co.'s campaign to defend itself in the wake of the recall of the pain reliever Vioxx intensified last week, as it placed a package of three full-page ads in seven prominent newspapers beginning last Friday. That follows several television appearances, as well as testimony before Congress by the company's chief executive.
615863
Merck failed to warn doctors about the risks of its painkiller Vioxx and must pay a retired FBI agent $50 million to compensate for the heart attack he suffered after taking the drug, a federal jury found Thursday.
93237
Merck & Co. Inc. MRK.N, reeling from  the recent withdrawal of its Vioxx arthritis drug, on Wednesday  said 2005 earnings will decline to levels below Wall Street  expectations, the third straight year of lower results.
162345
Merck & Co. Inc.  shares could rise to $70 by 2010 if the drugmaker continues to deliver on its promise of double-digit earnings growth, Barron's said in its October 29 edition.
597708
Drug giant Merck says the Food and Drug Administration wants more information, but is prepared to approve the company&#39;s successor drug to recalled pain reliever Vioxx.